Equillium Announces Pricing of Initial Public Offering

World News: . []

LA JOLLA Calif Oct 12 2018 GLOBE NEWSWIRE -- Equillium Inc (Nasdaq: EQ a biotechnology company leveraging deep understanding of immunobiology to develop products to treat severe autoimmune and inflammatory disorders with high unmet medic al need...

More news and information about Equillium, Inc.

Published By:

Globe Newswire: 13:25 GMT Friday 12th October 2018

Published: .

Search for other references to "equillium" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us